High dose intravenous labetalol for the resection of metastatic pheochromocytoma

Acta Anaesthesiologica Sinica

Volumn 34, Issue 4, 1996, Pages 235-238

  Chung, Chi Ho ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Labetalol; Paraganglioma; Pheochromocytoma. Antihypertensive agents

Indexed keywords

ANTIHYPERTENSIVE AGENT; LABETALOL;

ADRENAL TUMOR; ARTICLE; BLOOD PRESSURE; CASE REPORT; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; MIDDLE AGED; PHEOCHROMOCYTOMA;

ADRENAL GLAND NEOPLASMS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; INJECTIONS, INTRAVENOUS; LABETALOL; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA;

EID: 0030323048     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Rosei EA, Brown JJ, Lever AF, Robertson AS, Robertson JIS, Trust RM: Treatment of pheochromocytoma and of clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol 3(suppl):809-817, 1976.
2. Martin LE, Hopkins R, Bland R: Metabolism of labetalol by animal and man. Br J Clin Pharmacol 3(suppl):695-710, 1976.
3. Prichard BNC, Thompson FO, Boakes AJ, Joekes AM: Some hemodynamic effects of compound AH5158 compared with propanolol, propanolol plus hydrolazine and diazoxide: The use of AH5158 in the treatment of hypertension. Clin Sci Molec Med 48:97-100, 1975.